Organigram agrees to acquire Aurora for CAD 7.80 per share
ACB•Organigram will acquire Aurora for CAD 7.80 per share, valuing Aurora’s fully diluted equity at about CAD 561 million. The deal targets more than CAD 50 million in synergies and is expected to close in January 2027, subject to approvals.
1. Offer terms
Organigram will acquire Aurora for CAD 7.80 per share, valuing Aurora’s fully diluted equity at approximately CAD 561 million. The offer is a 93% premium to Aurora’s unaffected share price and a 21% premium to Curaleaf’s competing bid.
2. Payment and timing
Aurora shareholders can receive cash, shares or a combination, subject to proration. The combination targets more than CAD 50 million in synergies and would expand cannabis operations across Canada, Europe and Australia; completion is expected in January 2027, subject to shareholder, regulatory and court approvals.
